• 2022-09-27
    Last Updated
  • 200
    Pages

Adult Vaccines Market - Forecast(2022 - 2030)

DESCRIPTION
TABLE OF CONTENT

This Adult Vaccines research report will give you deep insights about the Adult Vaccines Market and it will also help you in strategic decision making. The final Adult Vaccines research document is an exhaustive document comprising of 250+ pages. All our reports are usually purchased across industries by Executives, Managers, Senior Managers, Strategy people, Directors, Vice Presidents, CXOs, etc. and help them in understanding about the various and Adult Vaccines market trends and analysis, competition, industry landscape, market size, market revenue, forecast, COVID-19 impact analysis, SWOT analysis, etc.

The Adult Vaccines key players profiled in this study includes: GlaxoSmithKline Plc, Merck & Co., Inc., Sanofi Pasteur, Pfizer, Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, AstraZeneca Plc, Novartis, Emergent BioSolutions, Inc., Abbott Laboratories, Inc., Janssen Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Ltd.., Valeant Pharmaceuticals International, Inc.

By Vaccine
Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type
Monovalent
Multivalent

By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

The state-of-the-art research on Adult Vaccines market, which is a detailed analysis of business space inclusive of the current market trends, competitive background, and size of the market. Encircling one or more parameters among analysis of the product, application potential, and global and regional growth strategies.

Speaking about this Adult Vaccines research report in particular, it includes:

  • Adult Vaccines realted Five Types of Segmentations (by Product Type, Power, Application, Distribution Channel, Region)
  • Adult Vaccines market Five Major Regions (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)
  • Adult Vaccines Market Information For 15 Years (2015 & 2030 – Historic Years, 2021 – Base Year and 2021-2030 Forecast Period)
  • Adult Vaccines Key Industry Dynamics including factors that are Driving the Market, Prevailing Deterrent, Potential Opportunities as Well as Future Trends for Adult Vaccines industry.
  • Ten Company Profiles related Adult Vaccines (these are not just Major Players but a Mix of Leading, Emerging Players, Market Disruptors, Niche Market Players, etc.)
  • Adult Vaccines Industry Landscape Analysis
  • Analysis of COVID-19 Impact on Adult Vaccines market at Global and Regional Level.

A thoroughgoing evaluation of the Adult Vaccines market restrains included in the report which represents the difference to drivers of the Adult Vaccines market and gives scope for strategic insights and developments. The research study has amalgamated the growth analysis of different aspects that enhance the market growth scenario. It constitutes key market drivers, restraints and trends that transform the market in either a positive or negative manner.

We are keen to understand what additional information if included will help you in your business endeavor. We also hold the expertise to customize the Adult Vaccines report based on any specific countries/regions, segmentations, companies, etc. of your choice. Hence you can share your specific requirements, if any.

The Table of Content for Adult Vaccines Market research study includes:

  1. Introduction
  2. Adult Vaccines Key Takeaways
  3. Adult Vaccines Research Methodology
  4. Adult Vaccines Market Landscape
  5. Adult Vaccines Market - Key Market Dynamics
  6. Adult Vaccines Market - Global Market Analysis
  7. Adult Vaccines Market - Revenue And Forecasts to 2030 – Type
  8. Adult Vaccines Market - Revenue And Forecasts to 2030 – Type of Product
  9. Adult Vaccines Market - Revenue And Forecasts to 2030 – Service
  10. Adult Vaccines Market Revenue And Forecasts to 2030 – Geographical Analysis
  11. Impact of Covid-19 Pandemic on Global Adult Vaccines Market
  12. Adult Vaccines Industry Landscape
  13. Adult Vaccines Market, Key Company Profiles
  14. Appendix
  15. List of Tables
  16. List of Figures

Additionally, in case you are interested in other topic at the moment, please share your exact requirements with us as apart from our off-the-shelf reports, we also provide customized reports that are prepared keeping in view the clients precise requirements. To let you know, on an annual basis, we publish over 450+ report across 18 distinct industry verticals.

Chapter 1 Global Adult Vaccines Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Adult Vaccines Market
1.4 Restraints for Adult Vaccines Market
1.5 Opportunities for Adult Vaccines Market
1.6 Trends for Adult Vaccines Market
1.7 COVID-19 Impact Assessment on Adult Vaccines Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Adult Vaccines Market Overview

2.1 Global Adult Vaccines Market by Product Type
2.1.1 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Adult Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Adult Vaccines Market by End User
2.2.1 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Adult Vaccines Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Adult Vaccines Market by Region
2.3.1 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Adult Vaccines Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Adult Vaccines Market Outlook (2013-2029)
2.4.1 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Adult Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Adult Vaccines Market Y-o-Y Growth Rate by Region
2.8.2 Global Adult Vaccines Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Adult Vaccines Market Y-o-Y Growth Rate by End User
2.9 Global Adult Vaccines Market Share Comparison (2013-2029)
2.9.1 Global Adult Vaccines Market Share by Region
2.9.2 Global Adult Vaccines Market Share by Product Type
2.9.3 Global Adult Vaccines Market Share by End User

Chapter 3 North America Adult Vaccines Market Overview

3.1 North America Adult Vaccines Market by Product Type
3.1.1 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Adult Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Adult Vaccines Market by End User
3.2.1 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Adult Vaccines Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Adult Vaccines Market by Region
3.3.1 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Adult Vaccines Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Adult Vaccines Market Outlook (2013-2029)
3.4.1 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Adult Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Adult Vaccines Market Y-o-Y Growth Rate by Region
3.8.2 North America Adult Vaccines Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Adult Vaccines Market Y-o-Y Growth Rate by End User
3.9 North America Adult Vaccines Market Share Comparison (2013-2029)
3.9.1 North America Adult Vaccines Market Share by Region
3.9.2 North America Adult Vaccines Market Share by Product Type
3.9.3 North America Adult Vaccines Market Share by End User

Chapter 4 Europe Adult Vaccines Market Overview

4.1 Europe Adult Vaccines Market by Product Type
4.1.1 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Adult Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Adult Vaccines Market by End User
4.2.1 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Adult Vaccines Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Adult Vaccines Market by Region
4.3.1 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Adult Vaccines Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Adult Vaccines Market Outlook (2013-2029)
4.4.1 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Adult Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Adult Vaccines Market Y-o-Y Growth Rate by Region
4.8.2 Europe Adult Vaccines Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Adult Vaccines Market Y-o-Y Growth Rate by End User
4.9 Europe Adult Vaccines Market Share Comparison (2013-2029)
4.9.1 Europe Adult Vaccines Market Share by Region
4.9.2 Europe Adult Vaccines Market Share by Product Type
4.9.3 Europe Adult Vaccines Market Share by End User

Chapter 5 Asia Pacific Adult Vaccines Market Overview

5.1 Asia Pacific Adult Vaccines Market by Product Type
5.1.1 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Adult Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Adult Vaccines Market by End User
5.2.1 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Adult Vaccines Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Adult Vaccines Market by Region
5.3.1 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Adult Vaccines Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Adult Vaccines Market Outlook (2013-2029)
5.4.1 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Adult Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Adult Vaccines Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Adult Vaccines Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Adult Vaccines Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Adult Vaccines Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Adult Vaccines Market Share by Region
5.9.2 Asia Pacific Adult Vaccines Market Share by Product Type
5.9.3 Asia Pacific Adult Vaccines Market Share by End User

Chapter 6 South America Adult Vaccines Market Overview

6.1 South America Adult Vaccines Market by Product Type
6.1.1 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Adult Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Adult Vaccines Market by End User
6.2.1 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Adult Vaccines Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Adult Vaccines Market by Region
6.3.1 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Adult Vaccines Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Adult Vaccines Market Outlook (2013-2029)
6.4.1 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Adult Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Adult Vaccines Market Y-o-Y Growth Rate by Region
6.8.2 South America Adult Vaccines Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Adult Vaccines Market Y-o-Y Growth Rate by End User
6.9 South America Adult Vaccines Market Share Comparison 2013-2029
6.9.1 South America Adult Vaccines Market Share by Region
6.9.2 South America Adult Vaccines Market Share by Product Type
6.9.3 South America Adult Vaccines Market Share by End User

Chapter 7 MEA Adult Vaccines Market Overview

7.1 MEA Adult Vaccines Market by Product Type
7.1.1 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Adult Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Adult Vaccines Market by End User
7.2.1 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Adult Vaccines Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Adult Vaccines Market by Region
7.3.1 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Adult Vaccines Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Adult Vaccines Market Outlook (2013-2029)
7.4.1 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Adult Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Adult Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Adult Vaccines Market Y-o-Y Growth Rate by Region
7.8.2 MEA Adult Vaccines Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Adult Vaccines Market Y-o-Y Growth Rate by End User
7.9 MEA Adult Vaccines Market Share Comparison (2013-2029)
7.9.1 MEA Adult Vaccines Market Share by Region
7.9.2 MEA Adult Vaccines Market Share by Product Type
7.9.3 MEA Adult Vaccines Market Share by End User

Chapter 8 Global Adult Vaccines Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
GlaxoSmithKline Plc
Merck & Co., Inc.
Sanofi Pasteur
Pfizer, Inc.
CSL Limited
Johnson & Johnson
Serum Institute of India
Medimmune
AstraZeneca Plc
Novartis
Emergent BioSolutions, Inc.
Abbott Laboratories, Inc.
Janssen Pharmaceuticals, Inc.
Takeda Pharmaceuticals Company Ltd..
Valeant Pharmaceuticals International, Inc.

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Licensing Options

One User
$3900
Enterprise User
$7800